MaxCyte, Inc. (NASDAQ:MXCT) experienced a significant 55.1% increase in short interest in January, reaching 3,881,689 shares, which accounts for 3.8% of the stock’s shares. The company, currently trading near its 12-month low of $0.68, has a market capitalization of approximately $76.8 million and is operating at a loss, with recent earnings and revenue missing analyst estimates. Analysts provide mixed ratings, with an average “Hold” and a price target of $7.00, while institutional investors hold about 68.8% of the shares.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
MaxCyte, Inc. (NASDAQ:MXCT) Short Interest Up 55.1% in January
MaxCyte, Inc. (NASDAQ:MXCT) experienced a significant 55.1% increase in short interest in January, reaching 3,881,689 shares, which accounts for 3.8% of the stock’s shares. The company, currently trading near its 12-month low of $0.68, has a market capitalization of approximately $76.8 million and is operating at a loss, with recent earnings and revenue missing analyst estimates. Analysts provide mixed ratings, with an average “Hold” and a price target of $7.00, while institutional investors hold about 68.8% of the shares.